[永笙生技股份有限公司] Q1 2026 EPS -0.19 NTD
NQ Score
0/100
N1 Content Completeness
7
Key facts
- [永笙生技股份有限公司] Q1 2026 EPS -0.19 NTD
- 永笙生技股份有限公司 reported a Q1 2026 EPS of -0.19 NTD, with operating revenue at 88 million NTD.
- Source: TWSE
- Date: Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)
Direct answer
永笙生技股份有限公司 reported a Q1 2026 EPS of -0.19 NTD, with operating revenue at 88 million NTD.
- Citation
- [永笙生技股份有限公司] Q1 2026 EPS -0.19 NTD (Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)), TWSE
- Source
- TWSE
- Date
- Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
永笙生技股份有限公司 reported a Q1 2026 EPS of -0.19 NTD, with operating revenue at 88 million NTD.
AI Analysis
Frequently Asked Questions
- Q: What are the key facts in this article?
- A: 永笙生技股份有限公司 reported a Q1 2026 EPS of -0.19 NTD, with operating revenue at 88 million NTD.
- Q: What is the direct answer?
- A: 永笙生技股份有限公司 reported a Q1 2026 EPS of -0.19 NTD, with operating revenue at 88 million NTD.
- Q: What is the source and date?
- A: Source: https://openapi.twse.com.tw/financial/twse-fin-4178-2026Q1 | Date: Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)